Rigel EVP receives 7,394 performance stock options
RIGEL PHARMACEUTICALS INC executive Raymond J. Furey received a fully vested employee stock option tied to a performance goal.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
RIGEL PHARMACEUTICALS INC executive Raymond J. Furey received a fully vested employee stock option tied to a performance goal. The award covers 7,394 shares of common stock at an exercise price of $22.49 per share. The performance metric was confirmed as met on June 17, 2026, triggering vesting, and the option expires on January 29, 2035. This is a compensation-related grant, not an open-market share purchase or sale.
Insider Trade Summary
Grant/Award: 7,394 shares
Grant/Award
1 txn
Insider
Furey Raymond J.
Role
EVP, GC, CCO & Corp Sec
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 7,394 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 7,394 contracts (Direct)
Footnotes (2)
- F1. The Reporting Person was granted a stock option with a performance-based condition with respect to 7,394 shares of the Issuer's common stock on January 29, 2025. The exercise price of this option is $22.49, which is the closing price of the Issuer's common stock on Nasdaq on the date of grant. In light of the performance-based vesting condition, this grant was not reportable under Section 16 until the performance metric was satisfied. On June 17, 2026, it was determined that the performance metric had been met.
- F2. The option was fully vested on June 17, 2026, the date the determination was made that the performance metric had been met.
Key Figures
Option shares granted: 7,394 shares
Exercise price: $22.49 per share
Shares following transaction: 7,394 option shares
+2 more
5 metrics
Option shares granted
7,394 shares
Employee stock option covering common stock
Exercise price
$22.49 per share
Closing price on Nasdaq on January 29, 2025
Shares following transaction
7,394 option shares
Total option shares held after this grant
Vesting date
June 17, 2026
Date performance metric determined met; option fully vested
Option expiration
January 29, 2035
Expiration date of the employee stock option
Key Terms
performance-based condition, exercise price, Section 16, employee stock option, +1 more
5 terms
performance-based condition financial
"The Reporting Person was granted a stock option with a performance-based condition with respect to 7,394 shares"
exercise price financial
"The exercise price of this option is $22.49, which is the closing price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Section 16 regulatory
"this grant was not reportable under Section 16 until the performance metric was satisfied"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
employee stock option financial
"security_title: Employee Stock Option (right to buy)"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
performance metric financial
"On June 17, 2026, it was determined that the performance metric had been met."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did RIGEL (RIGL) report for Raymond J. Furey?
RIGEL reported a grant of an employee stock option to Raymond J. Furey covering 7,394 shares of common stock. The option became fully vested when a performance metric was determined to be met on June 17, 2026, and reflects compensation rather than an open-market trade.
What is the exercise price of Raymond J. Furey’s new RIGEL stock option?
The option has an exercise price of $22.49 per share, equal to the closing price on Nasdaq on January 29, 2025, the grant date. This price is what must be paid per share to convert the option into common stock if exercised.
When did the performance condition for Raymond J. Furey’s RIGEL option vesting get satisfied?
The company determined on June 17, 2026, that the performance metric for the option grant had been met. As a result, the option became fully vested on that same date, converting from a performance-contingent award into a vested, exercisable stock option.
When does Raymond J. Furey’s RIGEL stock option reported here expire?
The employee stock option reported for Raymond J. Furey expires on January 29, 2035. Until that expiration date, and subject to plan terms, he can choose whether and when to exercise the option to buy RIGEL common shares at the fixed $22.49 price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
